Dei Biopharma to manufacture new HIV Drug for under $50 in Uganda
Ugandan biotechnology company Dei Biopharma has announced plans to manufacture a generic version of Lenacapavir (brand name: Yeztugo), a recently ...
Tag: Uganda biotech industry
Uganda’s Dei BioPharma Advances Diabetes Treatment with US FDA Application Approval
Kampala, Uganda — The U.S. Food and Drug Administration (FDA) has accepted an application from Uganda’s Dei BioPharma for the ...
Join us on this journey as we continue to be your trusted source for the bold, accurate, and authoritative news, information, and knowledge you need to stay informed, engaged, and inspired. Uganda's stories are worth telling, and UG Bulletin is here to bring them to you.
